Ochratoxin A-induced cytotoxicity in liver (HepG2) cells: Impact of serum concentration, dietary antioxidants and glutathione-modulating compounds

Journal of Applied Botany and Food Quality

Volumn 80, Issue 2, 2006, Pages 179-186

  Bösch Saadatmandi, Christine ^a   Hundhausen, Christoph ^a   Jofre Monseny, Laia ^a   Blank, Ralf ^a   Wolffram, Siegfried ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOAVAILABILITY; DIET; FUNGUS; PEPTIDE; PHENOL; PROTEIN; TOXICITY; TOXIN;

ASPERGILLUS; MAMMALIA; PENICILLIUM;

EID: 33845501450     PISSN: 16139216     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. ANDERSON, C.P., REYNOLDS, C.P., 2002: Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy. Bone Marrow Transplant. 30, 135-140.
2. ANDERSON, C.P., TSAI, J.M., MEEK, W.E., LIU, R.M., TANG, Y., FORMAN, H.J., REYNOLDS, C.P., 1999: Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis. Exp. Cell Res. 246, 183-192.
3. BABU, E., TAKEDA, M., NARIKAWA, S., KOBAYASHI, Y., ENOMOTO, A., TOJO, A., CHA, S.H., SERINE, T., SAKTHISEKARAN, D., ENDOU, H., 2002: Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim. Biophys. Acta. 1590, 64-75.
4. BALDI, A., LOSIO, M.N., CHELI, F., REBUCCI, R., SANGALLI, L., FUSI, E., BERTASI, B., PAVONI, E., CARLI, S., POLITIS, I., 2004: Evaluation of the protective effects of alpha-tocopherol and retinol against ochratoxin A cytotoxicity. Br. J. Nutr. 91, 507-512.
5. BENDELE, A.M., CARLTON, W.W., KROGH, P., LILLEHOJ, E.B., 1985: Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl. Cancer Inst. 75, 733-742.
6. BOSE, S., SINHA, S.P., 1994: Modulation of ochratoxin-produced genotoxicity in mice by vitamin C. Food Chem. Toxicol. 32, 533-537
7. BRUININK, A., RASONYI, T., SIDLER, C., 1998: Differences in neurotoxic effects of ochratoxin A, ochracin and ochratoxin-alpha in vitro. Nat. Toxins. 6, 173-177.
8. BRUININK, A., SIDLER, C., 1997: The neurotoxic effects of ochratoxin-A are reduced by protein binding but are not affected by 1-phenylalanine. Toxicol. Appl. Pharmacol. 146, 173-179.
9. CHU, F.S., 1971: Interaction of ochratoxin A with bovine serum albumin. Arch. Biochem. Biophys. 147, 359-366.
10. CHU, F.S., 1974: A comparative study of the interaction of ochratoxins with bovine serum albumin. Biochem. Pharmacol. 23, 1105-1113.
11. CREPPY, E.E., BAUDRIMONT, I., ANNE, M., 1998: How aspartame prevents the toxicity of ochratoxin A. J. Toxicol. Sci. 23 (Suppl. 2), 165-172.
12. CREPPY, E.E., KANE, A., DIRHEIMER, G., LAFARGE-FRAYSSINET, C., MOUSSET, S., FRAYSSINET, C., 1985: Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 28, 29-35.
13. CREPPY, E.E., LUGNIER, A.A., FASIOLO, F., HELLER, K., ROSCHENTHALER, R., DIRHEIMER, G., 1979: In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem. Biol. Interact. 24, 257-261.
14. D'ALESSIO, X.Y.??, 2004: Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells. Faseb J. 18, 1609-1611.
15. DOMIJAN, A.M., RUDES, K., PERAICA, M., 2005: The effect of ochratoxin A on the concentration of protein carbonyls in rats. Arh. Hig. Rada Toksikol. 56, 311-315.
16. ELBLING, L., WEISS, R.M., TEUFELHOFER, O., UHL, M., KNASMUELLER, S., SCHULTE-HERMANN, R., BERGER, W., MICKSCHE, M., 2005: Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. Faseb J. 19, 807-809.
17. FERRARESI, R., TROIANO, L., ROAT, E., LUGLI, E., NEMES, E., NASI, M., PINTI, M., FERNANDEZ, M.I., COOPER, E.L., COSSARIZZA, A., 2005: Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic. Res. 39, 1249-1258.
18. GALTIER, P., ALVINERIE, M., CHARPENTEAU, J.L., 1981: The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food Cosmet. Toxicol. 19, 735-738.
19. GALTIER, P., CHARPENTEAU, J.L., ALVINERIE, M., LABOUCHE, C., 1979: The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration. Drug Metab. Dispos. 7, 429-434.
20. GAUTIER, J.C., HOLZHAEUSER, D., MARKOVIC, J., GREMAUD, E., SCHILTER, B., TURESKY, R.J., 2001: Oxidative damage and stress response from ochratoxin a exposure in rats. Free Radic. Biol. Med. 30, 1089-1098.
21. GEKLE, M., SCHWERDT, G., FREUDINGER, R., MILDENBERGER, S., WILFLINGSEDER, D., POLLACK, V., DANDER, M., SCHRAMEK, H., 2000: Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 293, 837-844.
22. GRIFFITH, O.W., 1980: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
23. GUERRA, M.C., GALVANO, F., BONSI, L., SPERONI, E., COSTA, S., RENZULLI, C., CERVELLATI, R., 2005: Cyanidin-3-O-beta-glucopyranoside, a natural free-radical scavenger against aflatoxin B1- and ochratoxin A-induced cell damage in a human hepatoma cell line (Hep G2) and a human colonie adenocarcinoma cell line (CaCo-2). Br. J. Nutr. 94, 211-220.
24. HAGELBERG, S., HULT, K., FUCHS, R., 1989: Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9, 91-96.
25. HARVEY, R.B., ELISSALDE, M.H., KUBENA, L.F., WEAVER, E.A., CORRIER, D.E., CLEMENT, B.A., 1992: Immunotoxicity of ochratoxin A to growing gilts. Am. J. Vet. Res. 53, 1966-1970.
26. HENSLEY, K., BENAKSAS, E.J., BOLLI, R., COMP, P., GRAMMAS, P., HAMDHEY-DARI, L., Mou, S., PYE, Q.N., STODDARD, M.F., WALLIS, G., WILLIAMSON, K.S., WEST, M., WECHTER, W.J., FLOYD, R.A., 2004: New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic. Biol. Med. 36, 1-15.
27. HONDA, T., COPPOLA, S., GHIBELLI, L., CHO, S.H., KAGAWA, S., SPURGERS, K.B., BRISBAY, S.M., ROTH, J.A., MEYN, R.E., FANG, B., MCDONNELL, T.J., 2004: GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. Cancer Gene Ther. 11, 249-255.
28. HONG, J.T., PARK, K.L., HAN, S.Y., PARK, K.S., KIM, H.S., OH, S.D., LEE, R.D., JANG, S.J., 2000: Effects of ochratoxin A on cytotoxicity and cell differentiation in cultured rat embryonic cells. J. Toxicol. Environ. Health A. 61, 609-621.
29. HUNDHAUSEN, C., BOSCH-SAADATMANDI, C., AUGUSTIN, K., BLANK, R., WOLFFRAM, S., RIMBACH, G., 2005: Effect of vitamin E and polyphenols on ochratoxin A-induced cytotoxicity in liver (HepG2) cells. J. Plant Physiol. 162, 818-822.
30. IARC, 1991: Ochratoxin A. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 489-521. IARC Scientific Publ. No. 56. Lyon, France.
31. JUNG, K.Y., TAKEDA, M., KIM, D.K., TOJO, A., NARIKAWA, S., YOO, B.S., HOSOYAMADA, M., CHA, S.H., SEKINE, T., ENDOU, H., 2001: Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 69, 2123-2135.
32. KAMP, H.G., EISENBRAND, G., JANZOWSKI, C., KIOSSEV, J., LATENDRESSE, J.R., SCHLATTER, J., TURESKY, R.J., 2005: Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 49, 1160-1167.
33. KONTAXI, M., ECHKARDT, U., HAGENBUCH, B., STIEGER, B., MEIER, P.J., PETZINGER, E., 1996: Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. J. Pharmacol. Exp. Ther. 279, 1507-1513.
34. KUIPER-GOODMAN, T., SCOTT, P.M., 1989: Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2, 179-248.
35. LONG, L.H., CLEMENT, M.V., HALLIWELL, B., 2000: Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem. Biophys. Res. Commun. 273, 50-53.
36. MANACH, C., SCALBERT, A., MORAND, C., REMESY, C., JIMENEZ, L., 2004: Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747.
37. MEISNER, H., CHAN, S., 1974: Ochratoxin A, an inhibitor of mitochondrial transport systems. Biochemistry 13, 2795-2800.
38. METODIEWA, D., JAISWAL, A.K., CENAS, N., DICKANCAITE, E., SEGURA-AGUILAR, J., 1999: Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 26, 107-116.
39. MIKI, T., FUKUI, Y., UEMURA, N., TAKEUCHI, Y., 1994: Regional difference in the neurotoxicity of ochratoxin A on the developing cerebral cortex in mice. Brain Res. Dev. Brain Res. 82, 259-264.
40. MONNET-TSCHUDI, F., SORG, O., HONEGGER, P., ZURICH, M.G., HUGGETT, A.C., SCHILTER, B., 1997: Effects of the naturally occurring food mycotoxin ochratoxin A on brain cells in culture. Neurotoxicology. 18, 831-839.
41. MOORE, J.H., TRUELOVE, B., 1970: Ochratoxin A: inhibition of mitochondrial respiration. Science 168, 1102-1103.
42. O'BRIEN, E., DIETRICH, D.R., 2005: Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol. 35, 33-60.
43. OGRU, E., LIBINAKI, R., GIANELLO, R., WEST, S., MUNTEANU, A., ZINGG, J.M., AZZI, A., 2004: Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Ann. N. Y. Acad. Sci. 1031, 405-411.
44. OMAR, R.F., HASINOFF, B.B., MEJILLA, F., RAHIMTULA, A.D., 1990: Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 40, 1183-1191.
45. PETKOVA-BOCHAROVA, T., CHERNOZEMSKY, I.N., CASTEGNARO, M., 1988: Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit. Contam. 5, 299-301.
46. PETZINGER, E., ZIEGLER, K., 2000: Ochratoxin A from a toxicological perspective. J. Vet. Pharmacol. Ther. 23, 91-98.
47. RAHIMTULA, A.D., BEREZIAT, J.C., BUSSACCHINI-GRIOT, V., BARTSCH, H., 1988: Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37, 4469-4477.
48. RENZULLI, C., GALVANO, F., PIERDOMENICO, L., SPERONI, E., GUERRA, M.C., 2004: Effects of rosmarinic acid against aflatoxin B1 and ochratoxin-A-induced cell damage in a human hepatoma cell line (Hep G2). J. Appl. Toxicol. 24, 289-296.
49. REZK, B.M., HAENEN, G.R., VAN DER VIJGH, W.J., BAST, A., 2004: The extraordinary antioxidant activity of vitamin E phosphate. Biochim. Biophys. Acta. 1683 (1-3), 16-21.
50. RINGOT, D., CHANGO, A., SCHNEIDER, Y.J., LARONDELLE, Y., 2006: Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159, 18-46.
51. SCHAAF, G.J., NIJMEIJER, S.M., MAAS, R.F., ROESTENBERG, P., DE GROENE, E.M., FINK-GREMMELS, J., 2002: The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta. 1588, 149-158.
52. SIMON, P., GODIN, M., FILLASTRE, J.P., 1996: Ochratoxin a: a new environmental factor which is toxic for the kidney? Nephrol. Dial. Transplant. 11, 2389-2391.
53. STOJKOVIC, R., HULT, K., GAMULIN, S., PLESTINA, R., 1984: High affinity binding of ochratoxin A to plasma constituents. Biochem. Int. 9, 33-38.
54. STUDER-ROHR, I., SCHLATTER, J., DIETRICH, D.R., 2000: Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch. Toxicol. 74, 499-510.
55. VALACCHI, G., RIMBACH, G., SALIOU, C., WEBER, S.U., PACKER, L., 2001: Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology 165, 225-234.
56. VAN DER MERWE, K.J., STEYN, P.S., FOURIE, L., SCOTT, D.B., THERON, J.J., 1965: Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205, 1112-1113.
57. WEI, Y.H., LU, C.Y., LIN, T.N., WEI, R.D., 1985: Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology 36, 119-130.
58. WRIGHT, S.C., WANG, H., WEI, Q.S., KINDER, D.H., LARRICK, J.W., 1998: Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res. 58, 5570-5576.
59. ZURICH, M.G., LENGACHER, S., BRAISSANT, O., MONNET-TSCHUDI, F., PELLERIN, L., HONEGGER, P., 2005: Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. Neuroscience 134, 771-782.